新光药业
(300519)
| 流通市值：16.67亿 | | | 总市值：23.38亿 |
| 流通股本：1.14亿 | | | 总股本：1.60亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 560,282,924.88 | 503,416,125.46 | 424,612,128.76 | 470,553,459.72 |
| 应收票据及应收账款 | 7,860,335.88 | 11,800,922.88 | 17,009,136.33 | 10,117,686.1 |
| 应收账款 | 7,860,335.88 | 11,800,922.88 | 17,009,136.33 | 10,117,686.1 |
| 应收款项融资 | 723,142 | 777,484.3 | 707,601.2 | 721,734.75 |
| 预付款项 | 2,889,753.35 | 3,420,912.39 | 3,618,655.86 | 2,515,796.54 |
| 其他应收款合计 | 9,781.2 | 38,221.68 | 66,822.64 | 100,367.88 |
| 存货 | 49,402,199.45 | 69,337,496.63 | 61,700,552.13 | 63,694,762.26 |
| 其他流动资产 | 987,913.32 | 922,091.11 | 946,226.07 | 1,339,506.72 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 792,156,050.08 | 774,713,254.45 | 753,661,122.99 | 739,043,313.97 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 21,341,852.9 | 21,420,408.13 | 21,415,168.1 | 21,123,394.03 |
| 固定资产 | 101,901,532.06 | 105,521,867.76 | 109,011,905.77 | 112,614,156.97 |
| 在建工程 | 542,436.51 | - | 121,332.74 | 43,601.77 |
| 无形资产 | 7,803,491.85 | 7,876,147.64 | 7,948,803.43 | 8,020,757.22 |
| 递延所得税资产 | 188,643.46 | 249,657.39 | 293,371.73 | 197,850.54 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 131,777,956.78 | 135,068,080.92 | 138,790,581.77 | 141,999,760.53 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 923,934,006.86 | 909,781,335.37 | 892,451,704.76 | 881,043,074.5 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 50,291,005.97 | 56,008,538.21 | 55,286,366.71 | 62,739,855.6 |
| 应付账款 | 50,291,005.97 | 56,008,538.21 | 55,286,366.71 | 62,739,855.6 |
| 合同负债 | 2,554,722.2 | 70,141.12 | 363,748.68 | 666,711.19 |
| 应付职工薪酬 | 679,906.89 | 3,172,247.18 | 729,766.68 | 660,142.36 |
| 应交税费 | 5,957,111.88 | 7,178,146.72 | 7,935,946.99 | 1,556,914.36 |
| 其他应付款合计 | 814,662.85 | 4,167,182.37 | 1,178,226.84 | 1,383,628.03 |
| 其他流动负债 | 332,113.89 | 9,118.35 | 47,287.33 | 86,672.45 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 60,629,523.68 | 70,605,373.95 | 65,541,343.23 | 67,093,923.99 |
| 非流动负债: | | | | |
| 长期应付款 | 2,362,386.46 | 2,362,386.46 | 2,362,386.46 | 2,362,386.46 |
| 递延收益 | 5,935,257.96 | 6,281,745.36 | 6,628,232.74 | 6,189,720.14 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 8,297,644.42 | 8,644,131.82 | 8,990,619.2 | 8,552,106.6 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 68,927,168.1 | 79,249,505.77 | 74,531,962.43 | 75,646,030.59 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 160,000,000 | 160,000,000 | 160,000,000 | 160,000,000 |
| 资本公积 | 161,289,034.52 | 161,289,034.52 | 161,289,034.52 | 161,289,034.52 |
| 其他综合收益 | 3,239,318.03 | 3,306,089.98 | 3,301,635.95 | 3,053,627.99 |
| 盈余公积 | 116,924,680.74 | 116,924,680.74 | 111,923,292.31 | 111,923,292.31 |
| 未分配利润 | 413,553,805.47 | 389,012,024.36 | 381,405,779.55 | 369,131,089.09 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 855,006,838.76 | 830,531,829.6 | 817,919,742.33 | 805,397,043.91 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 855,006,838.76 | 830,531,829.6 | 817,919,742.33 | 805,397,043.91 |
| 负债和股东权益合计 | 923,934,006.86 | 909,781,335.37 | 892,451,704.76 | 881,043,074.5 |
| 公告日期 | 2025-04-28 | 2025-04-21 | 2024-10-24 | 2024-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |